Invention Grant
- Patent Title: Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
-
Application No.: US14138958Application Date: 2013-12-23
-
Publication No.: US09303077B2Publication Date: 2016-04-05
- Inventor: John M. Stewart
- Applicant: Soricimed Biopharma Inc.
- Applicant Address: CA Sackville, NB
- Assignee: Soricimed Biopharma Inc.
- Current Assignee: Soricimed Biopharma Inc.
- Current Assignee Address: CA Sackville, NB
- Agency: Bereskin & Parr LLP/S.E.N.C.R.L., s.r.l.
- Agent I. Laurence MacPhie
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K38/10 ; A61K38/00
Abstract:
The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
Public/Granted literature
- US20140187493A1 PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY Public/Granted day:2014-07-03
Information query
